Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hélène Lequeu1, Anne-Sophie Michallet1

  • 1Centre Léon-Bérard, Lyon, France.

La Revue Du Praticien
|December 5, 2018
PubMed
Summary
This summary is machine-generated.

Chronic lymphocytic leukemia (CLL) involves abnormal lymphocyte growth. Identifying clinical and biological prognostic factors is crucial for predicting patient outcomes and managing this complex leukemia.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors influencing front line treatment of chronic lymphocytic leukemia: A French real-world study.

Cancer·2026
Same author

Individualized physical activity program for older adults undergoing chemotherapy for hematologic malignancies.

Journal of geriatric oncology·2026
Same author

Measurable residual disease-guided combination of ibrutinib plus venetoclax versus FCR in previously untreated patients with intermediate-risk chronic lymphocytic leukaemia: a phase 2, randomised trial (ERADIC) from the FILO group.

EClinicalMedicine·2026
Same author

Targeted therapies overcome the poor prognosis of stereotyped Subset#2 chronic lymphocytic leukemia : a real-world multicentric study.

Leukemia·2025
Same author

Detection of potential complications in cancer survivors after chemotherapy and development of a regional care network: the PASCA feasibility study.

Frontiers in medicine·2025
Same author

Autologous and Allogeneic Stem-Cell Transplantation for Transformed Waldenström Macroglobulinemia.

American journal of hematology·2024
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Context:

  • Chronic lymphocytic leukemia (CLL) is the most common leukemia in Western countries.
  • It is defined by monoclonal B-lymphocyte proliferation exceeding 5,000/mm³ for over 3 months.
  • CLL presents with significant heterogeneity in clinical and biological manifestations.

Purpose:

  • To define the key prognostic factors in chronic lymphocytic leukemia.
  • To improve the clinical and biological classification of CLL.
  • To establish a more accurate evolutionary risk assessment for CLL patients.

Summary:

  • CLL is characterized by the monoclonal proliferation of mature lymphocytes.
  • Prognostic classification relies on both clinical (Binet stage) and biological factors.
Keywords:
Définition, classification et facteurs pronostiques de la leucémie lymphoïde chroniqueLeucémie lymphoïde chronique
  • The heterogeneity of CLL necessitates the identification of reliable prognostic indicators.

    • Impact:

    • Improved risk stratification for chronic lymphocytic leukemia patients.
    • Enhanced personalized treatment strategies based on prognostic factors.
    • Advancement in understanding the complex evolution of CLL.